1David. S. Alberts,David. Caldwell. Preface[J] 1985,Investigational New Drugs(2):79
2Dr Gerhard Ehninger,Barbara Proksch,Gerhard Heinzel,Erdmute Schiller,Karl-Heinz Weible,David L. Woodward. The pharmacokinetics and metabolism of mitoxantrone in man[J] 1985,Investigational New Drugs(2):109～116
3Niramol Savaraj,Katherine Lu,Valdivieso Manuel,Ti Li Loo. Pharmacology of mitoxantrone in cancer patients[J] 1982,Cancer Chemotherapy and Pharmacology(1):113～117
3Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1[M]. London: John widely & Sons Ltd, 2008: 276.
4Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analvsis[J]. Stat Med, 2002,21 ( 11 ) : 1 539.
5Luisa Q, Norman S, Michele E. A study of the strongly fluorescent species formed by the interaction of the dye 1, 4-dihydroxy-anthraquinone ( quinizarin ) with AI (Ⅲ ) [ J ]. Journal of Photochemistry and Photobiology A : Chemistu ,2003,155:79 - 91.
6黄振东 余文宪.蒽醌丙烯酸酯、酰胺的合成[J].化学学报,1981,39(2):165-169.
7Massa K, Kiyobumi T,Ting-Chao C,et al. Intercalating agents with covalent bond forming capability. A novel type of potential anticancer agents. 2. Derivatives of chrysophanol and emodin [J].J Med Chem, 1989,32 : 1594 - 1599.
8Haripada Khatuya. On the bromination of methyl 2-methyl-3-furoate[J]. Tetrahedron Letters ,2001,42:2643 - 2644.
9Tarek A ,Bemd L,Heinz F. An efficient synthesis of O-methyl protected emodin nitrile[J]. Chemical Monthly,2003,134 : 1113 - 1119.
10Ya-Lin Li, Wen-Fang Xu. Design, synthesis, and activity of caffeoyl pyrrolidine derivatives as potential gelatinase inhibitors[J]. Bioorg Med Chem,2004,12:5171 -5180.
